MedicalgorithmicsS.A. signed a contract with a global partner with a guaranteed minimumannual revenues of PLN 382,8 thousand

CurrentReport No: 22 / 2025

Date: August13, 2025

Legal Basis:Article 17(1) of the MAR Regulation - Confidential InformationMedicalgorithmicsS.A. with its registered office in Warsaw (the "Company";the "Issuer") informs that on August 13, 2025, it enteredinto a significant Agreement (the "Agreement") with aninternational partner from North American ("Partner").

In the opinionof the Company's Management Board, the conclusion of the Agreement isanother important step in the implementation of the Company's strategy,presented in current report No. 16/2023 of June 19, 2023, which is aimedat significantly increasing the Company's revenues and profitability(leveraging its high operational leverage) and generate positive cashflows. The agreement with the Partner - a North American deep-techcompany specializing in integrating advanced materials, sensors, andartificial intelligence (AI) - will enable the Company to develop in anew and promising segment of the smart textiles market.

The Agreementcovers the provision of certain services and the licensing of theleading DeepRhythmPlatform (DRP) software with DeepRhythmAI artificialintelligence algorithms (DRAI) for the analysis of ECG signals from thePartner's textile devices (the "ECG Product"). Thecontractual guaranteed minimum monthly remuneration for diagnostic testsperformed by the Partner will amount to PLN 31.9 thousand (EUR 7.5thousand) and will apply after four months from the completion ofintegration work enabling the Partner to commercially use the Company'sECG Product or from the Partner's (or its subcontractor's) examinationof the first patient, whichever occurs first. Upon fulfillment of theabove premises and assuming the provision of services for a period oftwelve consecutive months, the minimum guaranteed annual revenue underthe contract will amount to PLN 382.8 thousand.

Medicalgorithmicswill integrate the products and services held by the Partner in order toenable the Partner to perform ECG tests for its patients and provideservices under the Agreement using the ECG Product for services withinthe territory of Europe, USA, UAE, KSA, Israel and India with thepossibility of extension to further countries subject to mutual consentof the parties. The value of the remuneration (specified in EUR) for theservices provided will depend on the number of ECG sessions analyzedwith the Company's software in a given month at the agreed rate forsessions depending, among other things, on the length of the test andthe country in which the test was conducted, with a guaranteed minimummonthly remuneration (in EUR). The Partner will start paying fees forthe provision of services based on the number of session IDs afterMedicalgorithmics S.A. completes the integration enabling the Partner tocommercially provide services based on the ECG Product.TheAgreement was concluded for an indefinite period of time, with thepossibility of termination by either party, by the Partner with a180-day notice period, and by the Company with a 365-day notice period.In addition, the Agreement provides for the possibility of immediatetermination in the event of a material breach by one of the parties,following a prior ineffective notice to remedy the breach. The Agreementwas concluded in accordance with the laws of England and Wales andcontains standard provisions regarding representations and warranties,confidentiality, and indemnification, in line with industry standards.